NASDAQ: MBRX
Moleculin Biotech Inc Stock Ownership - Who owns Moleculin Biotech?

Insider buying vs selling

Have Moleculin Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald H. PickerChief Science Officer2026-06-2221$3.12
$65.52Sell
Walter V. KlempCEO and President2026-06-2288$3.12
$274.56Sell
Jonathan P. FosterChief Financial Officer2026-06-2241$3.12
$127.92Sell
Walter V. KlempCEO and President2026-06-2037$2.88
$106.56Sell
Jonathan P. FosterChief Financial Officer2026-06-2031$2.88
$89.28Sell
Donald H. PickerChief Science Officer2026-06-2013$2.88
$37.44Sell
Donald H. PickerChief Science Officer2025-11-042,131$0.50
$1.06kSell
Walter V. KlempCEO and President2025-11-047,001$0.50
$3.48kSell
Jonathan P. FosterChief Financial Officer2025-11-045,023$0.50
$2.50kSell

1 of 1

MBRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MBRX insiders and whales buy or sell their stock.

MBRX Shareholders

What type of owners hold Moleculin Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Waldemar Priebe68.32%3,645,573$9.62MInsider
Walter V. Klemp20.73%1,106,007$2.92MInsider
Donald H. Picker10.36%552,753$1.46MInsider
Sabby Management LLC1.41%75,021$198.06kInstitution
Geode Capital Management LLC0.61%32,329$85.35kInstitution
Robert E. George0.27%14,660$38.70kInsider
Vanguard Capital Management LLC0.26%13,869$36.61kInstitution
Hrt Financial LP0.26%13,739$36.27kInstitution
Jonathan P. Foster0.23%12,340$32.58kInsider
Vanguard Fiduciary Trust Co0.11%6,072$16.03kInstitution

1 of 3

MBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MBRX2.77%97.23%Net SellingNet Selling
XCUR0.25%99.75%Net Selling
JSPR24.49%75.51%Net Buying
BCDA0.35%99.65%Net BuyingNet Buying
INTS5.26%4.73%Net BuyingNet Buying

Moleculin Biotech Stock Ownership FAQ

Who owns Moleculin Biotech?

Moleculin Biotech (NASDAQ: MBRX) is owned by 2.85% institutional shareholders, 99.92% Moleculin Biotech insiders, and 0.00% retail investors. Waldemar Priebe is the largest individual Moleculin Biotech shareholder, owning 3.65M shares representing 68.32% of the company. Waldemar Priebe's Moleculin Biotech shares are currently valued at $8.75M.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.